Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Irritable Bowel Syndrome, February 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 75 articles:
HTML format


 

Single Articles

  1. NIESLER B, Kuerten S, Demir IE, Schafer KH, et al
    Disorders of the enteric nervous system - a holistic view.
    Nat Rev Gastroenterol Hepatol. 2021 Jan 29. pii: 10.1038/s41575-020-00385.
    PubMed    
    Abstract available

  2. KARAKAN T, Ozkul C, Kupeli Akkol E, Bilici S, et al
    Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  3. PALSSON OS, Peery A, Seitzberg D, Amundsen ID, et al
    Human Milk Oligosaccharides Support Normal Bowel Function and Improve Symptoms of Irritable Bowel Syndrome: A Multicenter, Open-Label Trial.
    Clin Transl Gastroenterol. 2020;11:e00276.
    PubMed    
    Abstract available

  4. STEIGER C, Phan NV, Sun H, Huang HW, et al
    Controlled Delivery of Bile Acids to the Colon.
    Clin Transl Gastroenterol. 2020;11:e00229.
    PubMed    
    Abstract available

  5. CHENG L, Luo QQ, Chen SL
    The role of intestinal mast cell infiltration in irritable bowel syndrome.
    J Dig Dis. 2021 Jan 29. doi: 10.1111/1751-2980.12971.
    PubMed    
    Abstract available

  6. KROUWEL M, Farley A, Ismail MT, Jolly K, et al
    Systematic review, meta-analysis with subgroup analysis of hypnotherapy for Irritable Bowel Syndrome, effect of intervention characteristics.
    Complement Ther Med. 2021 Jan 25:102672. doi: 10.1016/j.ctim.2021.102672.
    PubMed    
    Abstract available

  7. WANG FY, Chi CC
    Rosacea, Germs, and Bowels: A Review on Gastrointestinal Comorbidities and Gut-Skin Axis of Rosacea.
    Adv Ther. 2021 Jan 28. pii: 10.1007/s12325-021-01624.
    PubMed    
    Abstract available

  8. SWAIN S, Coupland C, Mallen C, Kuo CF, et al
    Temporal relationship between osteoarthritis and comorbidities: a combined case control and cohort study in the UK primary care setting.
    Rheumatology (Oxford). 2021 Jan 28. pii: 6121906.
    PubMed    
    Abstract available

  9. HORTON L, Al-Kourainy N, Kabbani D, Bishop CR, et al
    Challenging diagnosis of indolent systemic mastocytosis isolated to the GI tract.
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  10. EETEMADI A, Tagkopoulos I
    Methane and fatty acid metabolism pathways are predictive of Low-FODMAP diet efficacy for patients with irritable bowel syndrome.
    Clin Nutr. 2021 Jan 12. pii: S0261-5614(21)00013.
    PubMed    
    Abstract available

  11. QUITADAMO P, Isoldi S, Mallardo S, Zenzeri L, et al
    Scientific evidence for the treatment of children with irritable bowel syndrome.
    Curr Pediatr Rev. 2021 Jan 27. pii: CPR-EPUB-113721.
    PubMed    
    Abstract available


  12. Erratum for: Anti-Helicobacter pylori treatment can effectively improve the clinical remission rates of irritable bowel syndrome: a controlled clinical trial meta-analysis.
    Clinics (Sao Paulo). 2021;76:e1857err.
    PubMed    
    Abstract available

  13. BACHANI P, Kumar L, Kumar N, Memon MK, et al
    Prevalence and Symptom Characteristics of Irritable Bowel Syndrome Among Bronchial Asthma Patients in Pakistan.
    Cureus. 2020;12:e12231.
    PubMed    
    Abstract available

  14. SHAIDULLOV IF, Sorokina DM, Sitdikov FG, Hermann A, et al
    Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome.
    BMC Gastroenterol. 2021;21:37.
    PubMed    
    Abstract available

  15. ABOU-DONIA MB, Krengel MH, Lapadula ES, Zundel CG, et al
    Sex-Based Differences in Plasma Autoantibodies to Central Nervous System Proteins in Gulf War Veterans versus Healthy and Symptomatic Controls.
    Brain Sci. 2021;11.
    PubMed    
    Abstract available

  16. PASKARANANDAVADIVEL N, Lin AY, Cheng LK, Bissett I, et al
    ManoMap: an automated system for characterization of colonic propagating contractions recorded by high-resolution manometry.
    Med Biol Eng Comput. 2021 Jan 26. pii: 10.1007/s11517-021-02316.
    PubMed    
    Abstract available

  17. ONYIMBA F, Crowe SE, Johnson S, Leung J, et al
    Food allergies and Intolerances: A clinical approach to the diagnosis and management of adverse reactions to food.
    Clin Gastroenterol Hepatol. 2021 Jan 22. pii: S1542-3565(21)00075.
    PubMed    
    Abstract available

  18. PARKMAN HP, Wilson LA, Yates KP, Koch KL, et al
    Factors that contribute to the impairment of quality of life in gastroparesis.
    Neurogastroenterol Motil. 2021 Jan 25:e14087. doi: 10.1111/nmo.14087.
    PubMed    
    Abstract available

  19. MISONO S, Dietrich M, Piccirillo JF
    The Puzzle of Medically Unexplained Symptoms-A Holistic View of the Patient With Laryngeal Symptoms.
    JAMA Otolaryngol Head Neck Surg. 2020;146:550-551.
    PubMed    


  20. MAEDA K, Yamana T, Takao Y, Mimura T, et al
    Japanese Practice Guidelines for Fecal Incontinence Part 1-Definition, Epidemiology, Etiology, Pathophysiology and Causes, Risk Factors, Clinical Evaluations, and Symptomatic Scores and QoL Questionnaire for Clinical Evaluations-English Version.
    J Anus Rectum Colon. 2021;5:52-66.
    PubMed    
    Abstract available

  21. KHALILIAN A, Ahmadimoghaddam D, Saki S, Mohammadi Y, et al
    A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome.
    Biopsychosoc Med. 2021;15:3.
    PubMed    
    Abstract available

  22. GUO T, Patel SP, Shah D, Chi L, et al
    Optical clearing reveals TNBS-induced morphological changes of VGLUT2-positive nerve fibers in mouse colorectum.
    Am J Physiol Gastrointest Liver Physiol. 2021.
    PubMed    
    Abstract available

  23. LIN Z, Wang Y, Lin S, Liu D, et al
    Identification of potential biomarkers for abdominal pain in IBS patients by bioinformatics approach.
    BMC Gastroenterol. 2021;21:48.
    PubMed    
    Abstract available

  24. JIA H, Zhang Y, Si X, Jin Y, et al
    Quercetin Alleviates Oxidative Damage by Activating Nuclear Factor Erythroid 2-Related Factor 2 Signaling in Porcine Enterocytes.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  25. LI X, Li B, Zhang J, Chen T, et al
    Efficacy of opioid receptor modulators in patients with irritable bowel syndrome: A systematic review and meta-analysis.
    Medicine (Baltimore). 2021;100:e24361.
    PubMed    
    Abstract available

  26. NILHOLM C, Larsson E, Sonestedt E, Roth B, et al
    Assessment of a 4-Week Starch- and Sucrose-Reduced Diet and Its Effects on Gastrointestinal Symptoms and Inflammatory Parameters among Patients with Irritable Bowel Syndrome.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  27. ROMANO C, Pallio S, Cucinotta U, Accorsi P, et al
    Fibers in pediatric functional gastrointestinal disorders. practical considerations from clinical cases.
    Expert Rev Gastroenterol Hepatol. 2021.
    PubMed    
    Abstract available

  28. SHAH ED, Salwen-Deremer JK, Gibson PR, Muir JG, et al
    Pharmacologic, Dietary, and Psychological Treatments for Irritable Bowel Syndrome With Constipation: Cost Utility Analysis.
    MDM Policy Pract. 2021;6:2381468320978417.
    PubMed    
    Abstract available

  29. ENQI W, Jingzhu S, Lingpeng P, Yaqin L, et al
    Comparison of the Gut Microbiota Disturbance in Rat Models of Irritable Bowel Syndrome Induced by Maternal Separation and Multiple Early-Life Adversity.
    Front Cell Infect Microbiol. 2021;10:581974.
    PubMed    
    Abstract available

  30. KONTUREK TJ, Martinez C, Niesler B, van der Voort I, et al
    The Role of Brain-Derived Neurotrophic Factor in Irritable Bowel Syndrome.
    Front Psychiatry. 2021;11:531385.
    PubMed    
    Abstract available

  31. SINGH R, Thorat V, Kaur H, Sodhi I, et al
    Elucidating the Molecular Mechanism of Drug-Polymer Interplay in a Polymeric Supersaturated System of Rifaximin.
    Mol Pharm. 2021 Feb 12. doi: 10.1021/acs.molpharmaceut.0c01022.
    PubMed    
    Abstract available

  32. ERDMAN KA, Jones KW, Madden RF, Gammack N, et al
    Dietary Patterns in Runners with Gastrointestinal Disorders.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  33. SPILLER R
    Impact of Diet on Symptoms of the Irritable Bowel Syndrome.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  34. SEONG G, Lee S, Min YW, Jang YS, et al
    Effect of Heat-killed Lactobacillus casei DKGF7 on a Rat Model of Irritable Bowel Syndrome.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  35. JONES J, Lembo A, Heidelbaugh J, Kuritzky L, et al
    Management of irritable bowel syndrome with diarrhea: focus on eluxadoline.
    Curr Med Res Opin. 2021 Feb 10:1. doi: 10.1080/03007995.2021.1888705.
    PubMed    
    Abstract available

  36. BACHANI P, Kumar L, Kumar N, Fatima M, et al
    Prevalence of Irritable Bowel Syndrome and Frequency of Symptoms in the General Population of Pakistan.
    Cureus. 2021;13:e12541.
    PubMed    
    Abstract available

  37. RAAHAVE D, Jensen AK
    Increased colon transit time and faecal load in irritable bowel syndrome.
    World J Gastrointest Pharmacol Ther. 2021;12:13-20.
    PubMed    
    Abstract available

  38. FLORES V, Martinez-Lozano H, Bighelli F, Orcajo J, et al
    Prevalence of biliary acid malabsorption in patients with chronic diarrhoea of functional characteristics: a prospective study.
    BMC Gastroenterol. 2021;21:56.
    PubMed    
    Abstract available

  39. CIRIZA DE LOS RIOS C, Castel de Lucas I, Canga Rodriguez-Valcarcel F, Dieguez Pastor MDC, et al
    IRRITABLE BOWEL SYNDROME AND BASAL SERUM TRYPTASE: THE CORRELATION BETWEEN SUBTYPE, SEVERITY AND COMORBIDITIES. A PILOT STUDY.
    Rev Esp Enferm Dig. 2021 Feb 10. doi: 10.17235/reed.2021.7697/2020.
    PubMed    
    Abstract available

  40. DI STEFANO AFD, Radicioni MM, Vaccani A, Mazzetti A, et al
    Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX((R)) Modified Release Tablets in Healthy Male and Female Volunteers.
    Antibiotics (Basel). 2021;10.
    PubMed    
    Abstract available

  41. SUN YZ, Wang SL, Yu TY
    [Tiaoshen acupuncture method combined with electroacupuncture for diarrhea-type irritable bowel syndrome : a randomized controlled trial].
    Zhongguo Zhen Jiu. 2021;41:13-6.
    PubMed    
    Abstract available

  42. CHANDAN JS, Keerthy D, Gokhale KM, Bradbury-Jones C, et al
    The association between exposure to domestic abuse in women and the development of syndromes indicating central nervous system sensitisation: a retrospective cohort study using UK primary care records.
    Eur J Pain. 2021 Feb 8. doi: 10.1002/ejp.1750.
    PubMed    
    Abstract available

  43. ZHANG JD, Liu J, Zhu SW, Fang Y, et al
    Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation.
    Acta Pharmacol Sin. 2021 Feb 8. pii: 10.1038/s41401-020-00601.
    PubMed    
    Abstract available

  44. KRAMMER H, Storr M, Madisch A, Riffel J, et al
    [Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment - real-life data of a non-interventional study in Germany].
    Z Gastroenterol. 2021;59:125-134.
    PubMed    
    Abstract available

  45. THONG VD, Ngoc Phuc N, Quynh BTH
    Effectiveness of educational intervention carried out by clinical pharmacists for the quality of life of patients with irritable bowel syndrome: A randomized controlled trial.
    JGH Open. 2020;5:242-248.
    PubMed    
    Abstract available

  46. RIZEA-SAVU S, Duna SN, Sandulovici RC
    Single Dose Study Assessing the Pharmacokinetic and Metabolic Profile of Alverine Citrate in Healthy Volunteers.
    Front Pharmacol. 2021;11:620451.
    PubMed    
    Abstract available

  47. LEDERGERBER M, Lang BM, Heinrich H, Biedermann L, et al
    Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management.
    BMC Gastroenterol. 2021;21:53.
    PubMed    
    Abstract available

  48. YANG H, Liu X, Peng W, Chen R, et al
    Lipi Guben decoction in treating diarrheal irritable bowel syndrome: A study protocol for a randomized controlled trial.
    Medicine (Baltimore). 2021;100:e23887.
    PubMed    
    Abstract available

  49. GUPTA AK, Maity C
    Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant].
    Medicine (Baltimore). 2021;100:e23641.
    PubMed    
    Abstract available

  50. WANG B, Zhu S, Liu Z, Wei H, et al
    Increased Expression of Colonic Mucosal Melatonin in Patients with Irritable Bowel Syndrome Correlated with Gut Dysbiosis.
    Genomics Proteomics Bioinformatics. 2021 Feb 16. pii: S1672-0229(21)00018.
    PubMed    
    Abstract available

  51. LEMBO A, Kelley JM, Nee J, Ballou S, et al
    Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial.
    Pain. 2021 Feb 12. pii: 00006396-900000000-98118.
    PubMed    
    Abstract available

  52. CARMONA-SANCHEZ R, Carrera-Alvarez MA, Pena-Zepeda C
    Prevalence of primary eosinophilic colitis in patients with chronic diarrhea and diarrhea-predominant irritable bowel syndrome.
    Rev Gastroenterol Mex. 2021 Feb 15. pii: S0375-0906(21)00005.
    PubMed    
    Abstract available

  53. COUGHLAN S, Das A, O'Herlihy E, Shanahan F, et al
    The gut virome in Irritable Bowel Syndrome differs from that of controls.
    Gut Microbes. 2021;13:1-15.
    PubMed    
    Abstract available

  54. WEERTS ZZRM, Heinen KGE, Masclee AAM, Quanjel ABA, et al
    Correction: Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study.
    JMIR Mhealth Uhealth. 2021;9:e27998.
    PubMed    
    Abstract available

  55. WANG QS, Wang YL, Zhang WY, Li KD, et al
    Puerarin from Pueraria lobata alleviates the symptoms of irritable bowel syndrome-diarrhea.
    Food Funct. 2021 Feb 17. doi: 10.1039/d0fo02848.
    PubMed    
    Abstract available

  56. CHUAH KH, Beh KH, Rappek NAM, Mahadeva S, et al
    The Epidemiology and Quality of Life of Functional Gastrointestinal Disorders According to Rome III vs Rome IV Criteria: A Cross-sectional Study in Primary Care.
    J Dig Dis. 2021 Feb 17. doi: 10.1111/1751-2980.12975.
    PubMed    
    Abstract available

  57. VON WERNSDORFF M, Loef M, Tuschen-Caffier B, Schmidt S, et al
    Effects of open-label placebos in clinical trials: a systematic review and meta-analysis.
    Sci Rep. 2021;11:3855.
    PubMed    
    Abstract available

  58. XIE Y, Zhan X, Tu J, Xu K, et al
    Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF/c-kit and MLCK/MLC2 pathways.
    J Ethnopharmacol. 2021 Feb 13:113925. doi: 10.1016/j.jep.2021.113925.
    PubMed    
    Abstract available

  59. GOTA CE
    Fibromyalgia: Recognition and Management in the Primary Care Office.
    Med Clin North Am. 2021;105:285-296.
    PubMed    
    Abstract available

  60. STAUDACHER HM, Mikocka-Walus A, Ford AC
    Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials.
    Lancet Gastroenterol Hepatol. 2021 Feb 12. pii: S2468-1253(20)30363.
    PubMed    
    Abstract available

  61. VAN LANEN AS, de Bree A, Greyling A
    Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis.
    Eur J Nutr. 2021 Feb 14. pii: 10.1007/s00394-020-02473.
    PubMed    
    Abstract available

  62. CHAO G, Wang Z, Yang Y, Zhang S, et al
    LncRNA H19 as a Competing Endogenous RNA to Regulate AQP Expression in the Intestinal Barrier of IBS-D Patients.
    Front Physiol. 2021;11:602076.
    PubMed    
    Abstract available

  63. JI NN, Du L, Wang Y, Wu K, et al
    Small-Conductance Ca(2+)-Activated K(+) Channels 2 in the Hypothalamic Paraventricular Nucleus Precipitates Visceral Hypersensitivity Induced by Neonatal Colorectal Distension in Rats.
    Front Pharmacol. 2021;11:605618.
    PubMed    
    Abstract available

  64. KANCHIBHOTLA D, Sharma P, Subramanian S
    Improvement in Gastrointestinal Quality of Life Index (GIQLI) following meditation: An open-trial pilot study in India.
    J Ayurveda Integr Med. 2021 Feb 11. pii: S0975-9476(21)00008.
    PubMed    
    Abstract available

  65. WILMES L, Collins JM, O'Riordan KJ, O'Mahony SM, et al
    Of bowels, brain and behavior: A role for the gut microbiota in psychiatric comorbidities in irritable bowel syndrome.
    Neurogastroenterol Motil. 2021 Feb 13:e14095. doi: 10.1111/nmo.14095.
    PubMed    
    Abstract available

  66. STALLER KD
    Continuing Medical Education Questions: January 2021.
    Am J Gastroenterol. 2021;116:16.
    PubMed    
    Abstract available

  67. HON E, Gupta SK
    Gastrointestinal Food Allergies and Intolerances.
    Gastroenterol Clin North Am. 2021;50:41-57.
    PubMed    
    Abstract available

  68. CHAUDHRY NA, Jacobs C, Green PHR, Rampertab SD, et al
    All Things Gluten: A Review.
    Gastroenterol Clin North Am. 2021;50:29-40.
    PubMed    
    Abstract available

  69. HARER KN, Eswaran SL
    Irritable Bowel Syndrome: Food as a Friend or Foe?
    Gastroenterol Clin North Am. 2021;50:183-199.
    PubMed    
    Abstract available

  70. MARGOLIS KG, Cryan JF, Mayer EA
    The Microbiota-Gut-Brain Axis: From Motility to Mood.
    Gastroenterology. 2021 Jan 22. pii: S0016-5085(21)00268.
    PubMed    
    Abstract available

  71. FUKUDO S, Okumura T, Inamori M, Okuyama Y, et al
    Evidence-based clinical practice guidelines for irritable bowel syndrome 2020.
    J Gastroenterol. 2021 Feb 4. pii: 10.1007/s00535-020-01746.
    PubMed    
    Abstract available

  72. BOUCHOUCHA M, Deutsch D, Uong P, Mary F, et al
    Characteristics of patients with overlap functional gastrointestinal disorders.
    J Gastroenterol Hepatol. 2021 Feb 8. doi: 10.1111/jgh.15438.
    PubMed    
    Abstract available

  73. FU Y, Thomas R, Cares K
    Influence of Family History on Children with Irritable Bowel Syndrome.
    J Pediatr Gastroenterol Nutr. 2021 Jan 28. pii: 00005176-900000000-95778.
    PubMed    
    Abstract available

  74. MEIRA DE-FARIA F, Bednarska O, Strom M, Soderholm JD, et al
    Colonic paracellular permeability and circulating zonulin-related proteins.
    Scand J Gastroenterol. 2021 Feb 3:1-8. doi: 10.1080/00365521.2021.1879247.
    PubMed    
    Abstract available

  75. BEH KH, Chuah KH, Rappek NAM, Mahadeva S, et al
    The association of body mass index with functional dyspepsia is independent of psychological morbidity: A cross-sectional study.
    PLoS One. 2021;16:e0245511.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;